SI0979079T1 - Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination - Google Patents

Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination

Info

Publication number
SI0979079T1
SI0979079T1 SI9830677T SI9830677T SI0979079T1 SI 0979079 T1 SI0979079 T1 SI 0979079T1 SI 9830677 T SI9830677 T SI 9830677T SI 9830677 T SI9830677 T SI 9830677T SI 0979079 T1 SI0979079 T1 SI 0979079T1
Authority
SI
Slovenia
Prior art keywords
treating diseases
diseases causing
tetrahydropyridine derivatives
prepare medicines
causing demyelination
Prior art date
Application number
SI9830677T
Other languages
English (en)
Slovenian (sl)
Inventor
Bernard Bourrie
Pierre Casellas
Jean-Pierre Maffrand
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of SI0979079T1 publication Critical patent/SI0979079T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
SI9830677T 1997-04-29 1998-04-17 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination SI0979079T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9705275A FR2762514B1 (fr) 1997-04-29 1997-04-29 Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
PCT/FR1998/000774 WO1998048802A1 (fr) 1997-04-29 1998-04-17 Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
EP98921552A EP0979079B1 (fr) 1997-04-29 1998-04-17 Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation

Publications (1)

Publication Number Publication Date
SI0979079T1 true SI0979079T1 (en) 2004-10-31

Family

ID=9506415

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830677T SI0979079T1 (en) 1997-04-29 1998-04-17 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination

Country Status (18)

Country Link
US (1) US6344464B1 (xx)
EP (1) EP0979079B1 (xx)
JP (1) JP3956059B2 (xx)
AR (1) AR012504A1 (xx)
AT (1) ATE269077T1 (xx)
AU (1) AU7436498A (xx)
BR (1) BR9810234A (xx)
CA (1) CA2288241C (xx)
DE (1) DE69824576T2 (xx)
DK (1) DK0979079T3 (xx)
ES (1) ES2222593T3 (xx)
FR (1) FR2762514B1 (xx)
NO (1) NO325163B1 (xx)
PT (1) PT979079E (xx)
SI (1) SI0979079T1 (xx)
UY (1) UY24973A1 (xx)
WO (1) WO1998048802A1 (xx)
ZA (1) ZA983602B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
WO2002085888A1 (fr) * 2001-04-20 2002-10-31 Sanofi-Synthelabo Tetrahydropyridyl-alkyl-heterocycles, procede pour leur preparation et compositions pharmaceutiques les contenants
FR2823748B1 (fr) * 2001-04-20 2004-02-20 Sanofi Synthelabo Tetrahydropyridyl-alkyl-benzodiazines, procede pour leur preparation et compositions pharmaceutiques les contenant
WO2003002187A2 (en) * 2001-06-26 2003-01-09 Photomed Technologies, Inc. Multiple wavelength illuminator
CA2451955C (en) 2001-06-26 2015-09-29 Abgenix, Inc. Antibodies to opgl
FR2831166B1 (fr) * 2001-10-18 2004-02-27 Sanofi Synthelabo Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant
DK2213685T3 (en) 2002-09-06 2014-03-03 Medarex Llc Therapeutic anti-IL-1R1 monoclonal antibody
JP2006517191A (ja) * 2002-12-30 2006-07-20 アムジエン・インコーポレーテツド 共刺激因子を用いた併用療法
US7838522B2 (en) 2004-11-17 2010-11-23 Ares Trading S.A. Benzothiazole formulations and use thereof
JP5021488B2 (ja) 2004-12-21 2012-09-05 メルク セローノ ソシエテ アノニム スルホニルアミノ環式誘導体及びその使用
DK1844032T3 (da) 2005-01-31 2011-10-24 Merck Serono Sa N-hydroxyamid-derivater og deres anvendelse
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
KR20080036084A (ko) * 2005-07-15 2008-04-24 라보라뚜와르 세로노 에스. 에이. 자가면역 및／또는 염증성 질환 치료용 Ｇｌｅｐｐ―１억제제
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
CA2616479A1 (en) 2005-09-01 2007-03-08 Ares Trading S.A. Treatment of optic neuritis
EP2628727A3 (en) * 2007-11-21 2013-12-25 Decode Genetics EHF Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders
KR101707597B1 (ko) * 2010-12-07 2017-02-17 한국전자통신연구원 홀 센서리스 ｂｌｄｃ 모터용 전원 공급 모듈
WO2020035482A1 (en) 2018-08-13 2020-02-20 Iltoo Pharma Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof
WO2023118544A1 (en) 2021-12-23 2023-06-29 Cilcare Dev 4-phenyl-tetrahydropyridine derivatives for treating hearing diseases
WO2023222565A1 (en) 2022-05-16 2023-11-23 Institut National de la Santé et de la Recherche Médicale Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531707A1 (fr) 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
FR2662355B1 (fr) 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines
FR2740343B1 (fr) * 1995-10-26 1999-01-22 Sanofi Sa Utilisation de la 1-(2-napht-2-yl-ethyl)-4- (3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de la sclerose laterale amyotrophique

Also Published As

Publication number Publication date
PT979079E (pt) 2004-10-29
ZA983602B (en) 1998-11-02
CA2288241C (en) 2006-10-03
UY24973A1 (es) 1998-07-16
FR2762514B1 (fr) 1999-10-22
NO995245D0 (no) 1999-10-27
DK0979079T3 (da) 2004-10-25
EP0979079B1 (fr) 2004-06-16
WO1998048802A1 (fr) 1998-11-05
AR012504A1 (es) 2000-10-18
ES2222593T3 (es) 2005-02-01
NO995245L (no) 1999-12-27
JP2002501498A (ja) 2002-01-15
AU7436498A (en) 1998-11-24
CA2288241A1 (en) 1998-11-05
NO325163B1 (no) 2008-02-11
DE69824576D1 (de) 2004-07-22
JP3956059B2 (ja) 2007-08-08
BR9810234A (pt) 2000-09-19
EP0979079A1 (fr) 2000-02-16
DE69824576T2 (de) 2005-06-30
US6344464B1 (en) 2002-02-05
ATE269077T1 (de) 2004-07-15
FR2762514A1 (fr) 1998-10-30

Similar Documents

Publication Publication Date Title
SI0979079T1 (en) Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
HUP0003929A3 (en) Piperazine derivatives and their use for producing pharmaceutical compositions as anti-inflammatory agents and pharmaceutical compositions containing them
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
EP0831845A4 (en) DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS
HU9800291D0 (en) Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
HUP9900386A3 (en) Use of phenoxy-pyridine derivatives for producing pharmaceutical compositions suitable for treating heart failure
HUP0100170A3 (en) N-benzyl-3-indenylacetamides derivatives and use of them for producing pharmaceutical compositions for treating neoplasia
ZA898605B (en) Compositions for topical treatment of skin diseases
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
EP0911034A4 (en) MEDICAL COMPOSITION FOR THE TREATMENT OF HEART DISEASES CAUSED BY HEART HYPERTROPHY
PT879054E (pt) Aplicação de derivados de pirrolidina na preparação de medicamentos para o tratamento do abuso de drogas
HUP9801925A3 (en) Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions treating diseases caused by protozoons
IL106751A0 (en) Pharmaceutical compositions for the treatment of reversible obstructive airways diseases
AU6406098A (en) Use of minalcipran and its derivatives for preparing a medicine for treating certain psychiatric diseases
GB2243550B (en) Pharmaceutical anti-fungal use of cholane derivatives
CS22891A2 (en) Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
HUP9902167A3 (en) Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
HUP0004647A3 (en) Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
HUP9801985A3 (en) Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis
HUP0000569A3 (en) Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states